Allegrow Biotech Limited

Allegrow Biotech is a Hong Kong-based company specializing in the development of innovative artificial cell technology, specifically AimGel, to revolutionize cell therapy. The company focuses on expanding and activating immune cells with unparalleled efficiency, mimicking the immunological synapse. Allegrow Biotech was established in March 2022, as a spinoff start-up from the biomaterials laboratory at the Hong Kong University of Science & Technology. Their vision is to bring quality and cost-effective cell therapeutic products to patients, with a mission to innovate and deliver solutions for immune cell engineering, addressing the challenges in cell culture, particularly in culturing white blood cells – the immune cells.